- Home
- COOK vs ALEC Comparison
COOK vs ALEC Comparison
Compare COOK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COOK | ALEC |
|---|---|---|
| Founded | 1985 | 2013 |
| Country | United States | United States |
| Employees | N/A | 103 |
| Industry | Wholesale Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 262.7M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | COOK | ALEC |
|---|---|---|
| Price | $0.62 | $2.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $1.16 | ★ $4.83 |
| AVG Volume (30 Days) | 442.8K | ★ 862.5K |
| Earning Date | 06-11-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $559,520,000.00 | $21,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.50 | $45.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.48 | $0.87 |
| 52 Week High | $2.21 | $3.40 |
Technical Indicators
Market Signals| Indicator | COOK | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 31.69 | 59.42 |
| Support Level | N/A | $2.30 |
| Resistance Level | $1.16 | $2.53 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 30.84 | 62.50 |
Price Performance
Historical ComparisonAbout COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.